Emtux 500 mg Injection – Rituximab for Cancer & Autoimmune Disorders Emtux 500 mg Injection contains Rituximab, a monoclonal antibody used to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, granulomatosis with polyangiitis, and pemphigus vulgaris. Administered intravenously under medical supervision, it works by targeting and destroying specific immune cells to control disease progression. Emtux 500 mg Injection, Rituximab, Non-Hodgkin’s lymphoma, Chronic lymphocytic leukaemia, Rheumatoid arthritis treatment, Granulomatosis with polyangiitis, Pemphigus vulgaris therapy